Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma
Abstract Background Hepatocellular carcinoma (HCC) is one of the most common and lethal cancers worldwide. Wiskott–Aldrich syndrome protein family member 2 (WASF2) is an integral member of the actin cytoskeleton pathway, which plays a crucial role in cell motility. In this study, we aimed to explore...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2022-04-01
|
| Serier: | Journal of Experimental & Clinical Cancer Research |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s13046-022-02365-7 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
